May 14, 2026

The FDA’s Latest Peptide Decision: What It Signals for the Aesthetic Market 

The FDA’s recent decision to revisit restrictions on compounded peptides may appear, at first glance, to be a clinical or regulatory update. 

In reality, it’s something more: a signal about where the aesthetic industry is headed and how sophistication, compliance, and sustainable revenue quality are becoming central to long-term success. 

For wellness-focused practices, this moment isn’t just about peptides. It’s about how the market is evolving and what it takes to stay ahead of it. 

The Broader Industry Shift 

What’s happening with peptides is part of a larger transformation in aesthetic medicine. The industry is maturing. With that maturity comes greater scrutiny from regulators, more disciplined decision-making from investors and buyers, and higher expectations around compliance and standardization. 

Practices that have built on consistent, defensible foundations are finding themselves better positioned, not just operationally, but in how they’re perceived by partners, platforms, and the market at large. 

At the same time, interest in regenerative and longevity-focused treatments continues to grow. Peptides remain part of that conversation, but within a more defined framework. 

A More Nuanced Opportunity 

As the FDA continues its review process, the opportunity isn’t simply about whether peptides return to broader use. It’s about how practices integrate them going forward. Those who integrate peptides as thoughtful extensions of care within an evolving regulatory environment will be better positioned as the landscape clarifies. 

Clarity Changes the Conversation 

Regulatory clarity, when it comes, has a way of reshaping the market. It doesn’t just determine what’s allowed. It influences how businesses are built, how they grow, and how they’re ultimately evaluated. 

Practices that get ahead of these shifts building compliance infrastructure, diversifying revenue thoughtfully, and documenting clinical protocols tend to find that preparation compounds over time. The work done now shows up later, in ways that matter. 

The Bottom Line 

The FDA’s evolving stance on peptides is one step in a longer directional shift. And while the full impact will take time to unfold, one thing is already clear: in a more defined market, the practices that stand out will be those built on consistency, credibility, and long-term thinking. 

April 16, 2026

There’s No Zillow for Medical Aesthetic Practices 

You can check the value of your home in seconds. Your car? Even faster. 

But your practice, which is likely your largest asset, is a different story. 

There’s no Zillow or “Zestimate” available for that.  

Unlike real estate or public companies, MedSpa, dermatology clinic, plastic surgery clinic and wellness practice valuations aren’t transparent.

Transactions aren’t publicly reported, benchmarks vary widely, and online “rules of thumb” rarely reflect what buyers are actually paying in today’s market. As a result, many owners are operating without a clear understanding of what their practice may be worth or what truly drives that value. 

Why valuation clarity matters (even if you’re not selling) 

Valuation isn’t just about an exit. It’s a strategic tool. 

Understanding how your practice might be valued helps inform decisions around growth, hiring, provider compensation, service mix, and expansion. It can also highlight risks you may not see day-to-day. 

Too often, owners only seek valuation insight when a transition is already on the table. By then, opportunities to strengthen positioning may have passed. 

Removing the guesswork 

While there’s no single online tool that can instantly tell you what your medical spa is worth, valuation clarity isn’t out of reach. A thoughtful conversation grounded in current market activity can help you understand how buyers are thinking today and where your practice may stand by comparison. 

Whether you’re years away from a transition or simply want to run your business with better insight, knowing your valuation drivers puts you in control. It allows you to plan intentionally rather than operate blindly. 

And in a market that continues to evolve, clarity is one of the most valuable assets an owner can have. 

That’s one reason we start with a valuation first. In fact, we launched a valuation calculator recently to help practice owners gain a starting point. It’s not Zillow -we’re not plotting values on a map – but it does create a starting point for meaningful conversations about what drives value, how to improve it, and how that valuation aligns  with their personal goals.  

I invite you to try it out and if a calculator isn’t your thing, you’re always welcome to reach out to us directly. We’re happy to walk you through your practice value one-on-one.  

March 26, 2026

Join LuxMed for Fireside Chats with Industry Leaders at AMSPA 

Join the LuxMed team for our inaugural series of fireside chats with leading experts in the medical aesthetics industry during AMSPA’s Medical Spa Show in Vegas. Hosted by our President & CEO, Chris Hubble, these informal discussions will provide practical insights for MedSpa owners and operators focused on growth, operational excellence and preparing their businesses for long-term success. 

Each 30-minute session will feature experienced leaders sharing real-world perspectives on topics ranging from provider expansion and regulatory considerations to financial performance, operations and branding. 

Whether you are building your practice, optimizing performance or considering a future transaction, these conversations are designed to provide actionable takeaways you can apply to your business. 

Stop by Booth #241 and join us for these excellent discussions!  

Fireside Chat Schedule 

April 10 

11:30 – 12:00 
Amy Anderson, Founder & CEO, ACG Practice Partners 
What MedSpa owners should know before adding providers 

12:15 – 12:45 
Sam Pondrom, Partner, byrdadatto 
Regulatory considerations MedSpa owners should think about before going to market 

2:45 – 3:15 
Jessica Nunn, Founder & CEO, Maven 
EBITDA vs. Adjusted EBITDA: understanding the metrics that impact practice valuation 

April 11 

11:15 – 11:45 
Terri Ross, Founder & CEO, Terri Ross Consulting 
Operational foundations and building the right infrastructure before going to market 

12:00 – 12:30 
Mary Robb, Founder & CEO, Social Practice 
The role of branding and social media in strengthening practice outcomes

February 27, 2026

Leadership Strategies that Build Value in Medical Aesthetic Practices 

By Chris Hubble 

Strong medical aesthetic practices aren’t built on trends, tactics, or quick wins. They’re built on leadership that is consistent and intentional, creating stability today and lasting value for the future. 

After years of working alongside successful medical aesthetic practice owners, one truth is clear: practices that thrive long term — and ultimately sell for more — are led by owners who think beyond the treatment room. They lead like stewards of a business, not operators chasing the next idea, newest service or latest treatment.  

Leadership Starts With Vision, Not Volume 

Sustainable growth doesn’t come from simply doing more procedures or adding the latest device. It comes from a strategic vision. 

Effective leaders know where they want their practice to go in three, five, or even ten years. They make decisions that align with that direction. This long-term perspective creates consistency, which patients, staff, and future buyers all value. 

Build Systems  

Practices that depend too heavily on one provider, one manager, or the owner themselves are inherently fragile. Strong leadership focuses on systems. 

Well-defined processes, clear accountability, and standardized patient experiences allow practices to scale without sacrificing quality. More importantly, systems make a practice transferable which is a critical factor when the time comes to sell. 

Buyers don’t pay premiums for chaos. They pay for predictability. 

Develop Leaders at Every Level 

The most valuable practices are not owner dependent. They are team driven. 

High-performing practice owners invest in leadership development across the organization. Front desk leaders understand patient flow and conversion. Clinical leaders uphold standards and mentor others. Managers understand metrics, margins, and team performance. 

When leadership is distributed, the practice becomes resilient, able to grow, adapt and sustain success even as the owner steps back. 

Culture Is a Strategic Asset 

Culture is not a buzzword. It’s a business driver. 

Practices with strong, intentional cultures retain talent longer, deliver more consistent patient experiences, and outperform financially. Leadership sets the tone — through communication, expectations, and how challenges are handled. 

A healthy culture isn’t just good for morale; it directly impacts valuation. Buyers look closely at turnover, engagement, and operational stability because they know culture affects everything. 

Lead With the End in Mind 

Whether an owner plans to sell in two years or ten, the most successful leaders operate as if the practice will one day change hands. 

That means clean financials, documented processes, strong middle management, and a clear growth story. It also means resisting decisions that boost short-term cash flow at the expense of long-term value. 

Practices that sell for more are rarely built in a rush. They are built deliberately. 

The Role of the Owner Evolves 

As practices mature, the owner’s role should evolve from day-to-day operator to strategic leader. 

That shift allows the practice to grow without burnout, prepares the business for future transitions, and positions the owner to realize the full value of what they’ve built. 

The most successful medical aesthetic practice owners understand this evolution and embrace it early. 

February 11, 2026

Why Plastic Surgery Practices Are in the M&A Spotlight 

A few years ago, plastic surgery practices weren’t exactly the first specialty people mentioned when talking about healthcare consolidation. Today, that conversation has changed.  

Across healthcare, we’ve seen consolidation reshape everything for independent physicians and dentists. Now, plastic surgery and aesthetic medicine are having their moment. And it’s not happening by accident. Over the past several years, private equity and strategic buyers have increasingly focused on physician-led specialties with durable demand, strong margins, and brand-driven growth – plastic surgery checks all three boxes. 

From Independent Practices to Strategic Assets 

Buyers are underwriting not just today’s earnings, but whether a practice can grow without being entirely dependent on one surgeon. For decades, most plastic surgery practices were built around a single surgeon, a loyal patient base, and a strong local reputation. Many still are, and that’s part of what makes the space so attractive. 

The market remains highly fragmented, with thousands of independent practices operating efficiently but largely on their own. For investors and strategic buyers, that kind of fragmentation signals opportunity. They’re making investments designed to scale, professionalize operations and build platforms that can grow well beyond one location or one physician. 

In fact, investor interest has surged. More than $3 billion has flowed into the medical aesthetics sector over the past five years, a clear signal that buyers see long-term value in plastic surgery and adjacent services, not just short-term returns. 

Why Deals Are Accelerating Now 

Plastic surgery M&A activity has jumped dramatically, with transaction volume increasing more than fourfold over the past two years. That kind of growth doesn’t happen unless several forces line up at once. 

First, plastic surgery practices benefit from cash-pay economics. They aren’t as exposed to reimbursement volatility as many other specialties, which makes revenue more predictable and margins more attractive. 

Second, consumer demand keeps growing. Aesthetic procedures — both surgical and non-surgical — have become more mainstream, crossing age groups, genders and geographies. That demand creates resilience, even in uncertain economic cycles. 

Finally, many practices are already doing the hard work of building strong brands. Buyers aren’t looking to reinvent these practices; they’re looking to scale what already works. 

What This Means for Practice Owners 

For plastic surgeons, this wave of activity is less about pressure to sell and more about optionality.   

Some owners want partial liquidity while continuing to practice. Others are thinking about succession planning or reducing administrative burden. Still, others are simply curious what their life’s work might be worth in today’s market. 

The practices that attract the most interest tend to share a few traits: 

• Diversified revenue across cosmetic and reconstructive services 

• Strong operational infrastructure and team depth 

• Clear growth story beyond a single provider 

None of those happen overnight. But they’re achievable for owners who want to keep their options open. 

This Isn’t a Trend. It’s a Transition. 

What we’re seeing in plastic surgery mirrors what’s already happened in other physician-led specialties. Consolidation doesn’t replace clinical excellence, it amplifies it when done thoughtfully. 

The practices that will thrive in the next phase aren’t just great clinically. They’re intentional about strategy, scale and long-term planning. 

An active M&A market doesn’t mean every plastic surgery practice should be looking to sell. But it does mean owners should have a clear understanding of their value and the strategic choices available to them. 

Understanding value, optionality, and timing doesn’t require committing to a transaction. But it does require preparation. The owners who benefit most from today’s market are the ones who start the process early, understand their goals, and think intentionally about the next chapter, on their own terms.  

January 9, 2026

Looking Ahead to 2026: What I’m Hearing from Medical Aesthetic Practice Owners Every Day

By Chris Hubble, President & CEO, LuxMed Transition Strategies

Every week, I sit across from medical aesthetic practice owners at different stages in their practices. Some are thinking about expanding. Some are wondering whether now the right moment is to sell. Some simply want to understand what the future holds for medical aesthetic practices during this time of consolidation and market growth. 

When you talk to as many owners as I do, patterns start to emerge. And those conversations shape how I see 2026 unfolding.

The patient journey is evolving fast

Owners tell me their schedules are full, but the type of demand is shifting. Patients are beginning treatment in one-off procedures and then expanding towards long-term, relationship-driven treatment plans. They want providers who understand their aesthetic goals and wellness aspirations, offering comprehensive services to help them meet their goals. Combination treatments, preventive strategies and curated experiences are becoming the norm.

This shift isn’t slowing down in 2026, it’s accelerating.

There is still value in specialization

While on the road a lot last year, I spoke with practice owners who are overwhelmed. This medical aesthetics industry is on a steady drumbeat telling practice owners to do more, especially in the wellness space. Attend any industry conference and you’ll hear voices telling you to add more services, buy the latest laser, deliver more wellness solutions and the list goes on.

While service diversification and innovation are important, it’s equally important to stay in a lane and excel at what you do best.This is especially true if you have goals to sell your practice. Our numbers show that there is 165% more buyer interest in practices with a clear service line strategy compared to those that split between MedSpa and wellness services.

With the medical aesthetics market growing rapidly, expect to receive more pressure to do more in  2026. However, it’s in your best interest not to let that noise influence your decisions about the services you offer, especially if you are considering selling in the next year.

Consolidation is here to stay

I can’t tell you how many conversations start with the question, “Is this the right time to sell?”.

And the answer is it might be depending on what you want and how prepared you are. With such a high volume of medical aesthetic practice growth, buyers are selective. They’re active and what they want is clear: stable cash flow, strong teams and patient base, repeatable processes and growth potential.

But what owners want is just as important. Some want an exit. Some want a partner. Some just want relief with help carrying the load so they can get back to practicing. 2026 will be shaped by owners choosing paths that fit their lifestyle and long-term goals, not just their financial ones.

What this means for the road ahead

If there’s one message I’d share with every MedSpa, aesthetic practice, dermatology, plastic surgery or wellness clinic owner heading into 2026, it’s that your practice is more valuable and more complex than ever. And the choices you make over the next 12–18 months will determine what your future looks like.

Whether you want to grow, partner, sell, or simply prepare for what’s ahead, you don’t have to navigate these decisions alone. The conversations I’m having every day help shape the future of this industry and I’m always here to talk through what’s possible for you and your practice. In the meantime, keep a pulse on the patient journey, hone your offerings so you stay in a lane and tighten financial systems so you can begin thinking strategically about growth and long-term value. Buyers are noticing.

December 12, 2025

Six Common Assumptions About Aesthetic Practice Transitions and What’s Actually True

For many aesthetic medical practice owners, transitions can feel like stepping into a fog. In a market full of rapid growth and consolidation, myths often take hold far too fast. When we first engage with a practice owner, we find they’re sorting through rumors, half-truths and well-meaning advice that doesn’t quite fit their reality. That confusion can lead to hesitation or worse, decisions made too late or without the right information and representation.

At LuxMed, we believe clarity changes everything. So we’re breaking down five of the most common myths we hear from practice owners and replacing them with the truths that lead to smarter, more confident transitions.

Myth #1: “I’m not at retirement age – why waste my time thinking about transition strategies now?”

Waiting may limit your upside. Practice value is often highest during peak growth years, not always at the end of a career. Earlier planning allows for better financial outcomes, leadership transition strategies, and succession planning.

The Truth: Exploring early doesn’t commit you. It simply empowers you.

Myth #2: “Selling my practice means losing control.”

Many practice owners assume that selling or partnering with an investor means sacrificing autonomy. The reality? Modern transitions are built around aligned incentives. Practice owners often maintain decision-making authority around clinical operations, staffing oversight, and the culture they’ve built while gaining support on the administrative burden.

The Truth: A well-structured transition increases control over your time and reduces operational stress.

Myth #3: “Only struggling practices consider selling.”

High-performing practices are often the ones who gain the most value from transitions. They’re attractive to investors and have strong negotiating leverage.

The Truth: Thriving practices can maximize valuation, expand service lines and strengthen negotiation power.

Myth #4: “Every transition model is the same.”

Private equity partnerships, MSOs, practice mergers, hospital acquisitions, and physician-owned models all carry unique benefits and risk profiles. No two deals are alike.

The Truth: Customization is essential. From equity structure to governance to earn-outs. The right partner should be tailored to your goals, culture, and future vision.

Myth #5: “My colleague had a great experience with a buyer so I will too.”

No two practices are alike, so aligning with a buyer based on a friend or colleague’s experience is not a good strategy. You have to evaluate multiple buyers and choose the offer that’s right for you, supports your practice goals and your work/life plans.

The Truth: Open up your options. Get the guidance you need to evaluate multiple offers that support your goals.

Myth #6: “I’ll make more money selling directly to a buyer without a broker.”

It’s a common assumption that avoiding an advisor means keeping more of the deal. In reality, direct-to-buyer conversations often reduce leverage, limit competition and expose owners to unfavorable terms. Strategic buyers negotiate acquisitions every day. Most practice owners do not.

The Truth: A structured, advisor-led process delivers a stronger overall outcome.

Experienced brokers create competitive tension among qualified buyers, uncover value beyond headline price and negotiate key terms. The result is a higher net outcome, fewer surprises, and a smoother, more protected transition.

Practice transitions aren’t one-size-fits-all and the best outcomes happen when owners replace assumptions with real data, clear goals and a thoughtful process.

Whether you’re thinking about growth, partnership, succession or simply what’s possible in the next chapter, understanding these truths is the first step toward a transition that protects what you’ve built and supports where you want to go next.

Our team at LuxMed is here to help you move forward with clarity whenever the time is right for you.

October 24, 2025

Beyond Revenue: The Hidden Drivers of Medical Aesthetic Practice Value

When medical aesthetics practices, medspas, dermatology clinics, plastic surgery practices and wellness practice owners think about valuation, revenue and profit margins usually take center stage. While financial performance is essential, it is far from the only factor that determines the long-term value of your medical aesthetic practice. In today’s evolving marketplace, buyers and investors are looking beyond the numbers to understand what truly drives sustainable growth.

Here are three key additional drivers of value that every practice owner should know.

Service Diversification

A practice that relies too heavily on one or two services is vulnerable to market shifts, competitive pressure, and changing consumer trends. For example, we’re seeing that with practices that centered their businesses solely on semaglutides or nonsurgical fat freezing services. Service diversification creates stability and resilience. By offering a balanced mix of treatments including injectables, lasers, skin care and wellness add-ons, you not only expand your revenue streams but also position your practice as a comprehensive destination for patients. Buyers view this as a sign of adaptability and future-proofing.

Provider Depth

Aesthetic outcomes, patient satisfaction and revenue growth all depend on the collective skill, consistency and reputation of those delivering care. Practices with a balanced mix of physicians, experienced injectors, physician assistants and licensed aestheticians offer flexibility, scalability and a superior patient experience. Depth across these roles ensures patients can access a full continuum of services while maintaining trust and continuity of results. For investors, a deep and well-integrated provider bench signals operational resilience, protects against turnover risk and indicates a mature practice poised for sustained growth under new ownership.

Patient Loyalty and Outcomes

Repeat business and word-of-mouth referrals are gold in aesthetics. A loyal patient base reflects both quality outcomes and an outstanding patient experience. Practices that consistently achieve strong patient retention rates are valued higher because they represent a stable, predictable revenue foundation. Loyalty also signals brand equity.

Maximizing Your Practice’s True Potential

Revenue is only part of the story. Service diversification, team culture, and patient loyalty all play critical roles in shaping your practice’s long-term value. By recognizing and strengthening these drivers, you uncover hidden potential that significantly enhances your position in today’s competitive M&A landscape.

At LuxMed, we help practice owners see beyond revenue to understand the complete picture of their value. Our advisory approach ensures that when the time comes to scale, sell, or partner, you maximize both financial outcomes and legacy impact.

Ready to uncover the hidden value in your practice? Contact us today to start the conversation.